These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11089306)

  • 21. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006.
    Su X; Jiang F; Qimuge ; Dai X; Sun H; Ye S
    Sex Transm Dis; 2007 Dec; 34(12):995-9. PubMed ID: 17595594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe.
    Martin IM; Hoffmann S; Ison CA;
    J Antimicrob Chemother; 2006 Sep; 58(3):587-93. PubMed ID: 16816397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.
    Bala M; Ray K; Gupta SM; Muralidhar S; Jain RK
    J Antimicrob Chemother; 2007 Sep; 60(3):582-6. PubMed ID: 17604320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004.
    Stathi M; Flemetakis A; Miriagou V; Avgerinou H; Kyriakis KP; Maniatis AN; Tzelepi E
    J Antimicrob Chemother; 2006 Apr; 57(4):775-9. PubMed ID: 16492719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.
    Tapsall JW; Ndowa F; Lewis DA; Unemo M
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):821-34. PubMed ID: 19735224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
    Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
    N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic resistance in Neisseria gonorrhoeae.
    Tapsall JW
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S263-8. PubMed ID: 16032562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annual report of the Australian Gonococcal Surveillance Programme, 1997.
    Commun Dis Intell; 1998 Oct; 22(10):212-6. PubMed ID: 9803596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.
    Chan DJ; Tapsall J
    Int J STD AIDS; 2006 Jun; 17(6):410-2. PubMed ID: 16734965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonococcal antimicrobial resistance in the Western Pacific Region.
    Lahra MM; Lo YR; Whiley DM
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv19-23. PubMed ID: 24243875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annual report of the Australian Gonococcal Surveillance Programme, 1998.
    Commun Dis Intell; 1999 Jul; 23(7):193-7. PubMed ID: 10476608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial sensitivity of Neisseria gonorrhoeae to spectinomycin & rosoxacin.
    Bhujwala RA; Bhargava NC; Biswas TD; Narain S; Pandhi RK
    Indian J Med Res; 1987 Dec; 86():702-6. PubMed ID: 2967246
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006.
    Tapsall JW; Limnios EA; Murphy D;
    J Antimicrob Chemother; 2008 Jan; 61(1):150-5. PubMed ID: 17986492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annual report of the Australian Gonococcal Surveillance Programme, 1999.
    Tapsall J
    Commun Dis Intell; 2000 May; 24(5):113-7. PubMed ID: 11085015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistance of Neisseria gonorrhoeae to 4 antibiotics: an analysis of the situation in Guangzhou in 2002].
    Fei S; Luo Q; Cao WL; Zhang XB
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1099-100. PubMed ID: 14559707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
    Matsumoto T
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annual report of the Australian Gonococcal Surveillance Programme, 2000.
    Commun Dis Intell Q Rep; 2001 Apr; 25(2):59-63. PubMed ID: 11432529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
    Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
    J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Gonococcal Antimicrobial Surveillance Programme (GASP). WHO western Pacific region, 1995.
    Wkly Epidemiol Rec; 1997 Jan; 72(5):25-7. PubMed ID: 9030034
    [No Abstract]   [Full Text] [Related]  

  • 40. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins.
    Tapsall JW
    Curr Opin Infect Dis; 2009 Feb; 22(1):87-91. PubMed ID: 19532086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.